- Home
- BCAB vs GRNQ Comparison
BCAB vs GRNQ Comparison
Compare BCAB & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- GRNQ
- Stock Information
- Founded
- BCAB 2007
- GRNQ 2013
- Country
- BCAB United States
- GRNQ Malaysia
- Employees
- BCAB N/A
- GRNQ N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- GRNQ EDP Services
- Sector
- BCAB Health Care
- GRNQ Technology
- Exchange
- BCAB Nasdaq
- GRNQ Nasdaq
- Market Cap
- BCAB 19.9M
- GRNQ 16.4M
- IPO Year
- BCAB 2020
- GRNQ 2018
- Fundamental
- Price
- BCAB $0.33
- GRNQ $1.68
- Analyst Decision
- BCAB Buy
- GRNQ
- Analyst Count
- BCAB 2
- GRNQ 0
- Target Price
- BCAB $1.00
- GRNQ N/A
- AVG Volume (30 Days)
- BCAB 811.8K
- GRNQ 82.6K
- Earning Date
- BCAB 08-11-2025
- GRNQ 08-12-2025
- Dividend Yield
- BCAB N/A
- GRNQ N/A
- EPS Growth
- BCAB N/A
- GRNQ N/A
- EPS
- BCAB N/A
- GRNQ N/A
- Revenue
- BCAB $11,000,000.00
- GRNQ $3,190,761.00
- Revenue This Year
- BCAB N/A
- GRNQ N/A
- Revenue Next Year
- BCAB N/A
- GRNQ N/A
- P/E Ratio
- BCAB N/A
- GRNQ N/A
- Revenue Growth
- BCAB N/A
- GRNQ N/A
- 52 Week Low
- BCAB $0.24
- GRNQ $0.80
- 52 Week High
- BCAB $2.53
- GRNQ $2.50
- Technical
- Relative Strength Index (RSI)
- BCAB 38.71
- GRNQ 42.34
- Support Level
- BCAB $0.33
- GRNQ $1.50
- Resistance Level
- BCAB $0.37
- GRNQ $2.24
- Average True Range (ATR)
- BCAB 0.04
- GRNQ 0.19
- MACD
- BCAB -0.00
- GRNQ -0.08
- Stochastic Oscillator
- BCAB 5.26
- GRNQ 20.52
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About GRNQ Greenpro Capital Corp.
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.